imd BIOTECH key facts
as of Oct 2026- Developer of a next-generation food pathogen identification technology designed to eliminate the trade-off between accuracy and speed in food safety testing.
- imd BIOTECH is valued at approximately $8.0M as of Oct 2026 (last reported valuation).
- It has raised $2.1M; the latest was Seed Round ($5.9M) in Jan 2026.
- Notable investors include Superangels, Austria Wirtschaftsservice, CK Venture Capital, Gernot Rericha, Nikolaus Futter — 7 tracked in total.
- Status: Privately Held (backing).
imd BIOTECH's last reported valuation, May 2024. Nothing priced has surfaced since.
- ·Watch imd BIOTECH: the Monday email on marks, rounds and moves
imd BIOTECH funding rounds
No funding rounds for imd BIOTECH are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
imd BIOTECH valuation
imd BIOTECH's last reported valuation was $8 million in May 2024. No priced round, secondary trade or fund mark has surfaced since.
imd BIOTECH investors
7 investors are on record for imd BIOTECH, including Superangels, Austria Wirtschaftsservice, CK Venture Capital and Gernot Rericha.
About imd BIOTECH
Developer of a next-generation food pathogen identification technology designed to eliminate the trade-off between accuracy and speed in food safety testing. The company offers real-time bacterial growth detection without external enrichment and a simplified one-step preparation workflow, enabling food producers and safety labs to make faster and more informed decisions.
- Sector
- Materials and Resources
- HQ
- Vienna, Austria
- Founded
- 2021
- Employees
- 13
- Website
- imdbiotech.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.